Pharmaceutical Glass Packaging Market Report 2026

Pharmaceutical Glass Packaging Market Overview

• Pharmaceutical Glass Packaging market size has reached to $16.12 billion in 2025 • Expected to grow to $27.35 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: Pharmaceutical Industry Surge Propels Growth In The Pharmaceutical Glass Packaging Market • Market Trend: Unveiling Pharmacos Packaging Line Redefining Glass Jars For Pharmaceutical Excellence And Sustainability • North America was the largest region in 2025.

The key promising market opportunities in the pharmaceutical glass packaging market include: • Vials (Segmentation By Product) → Expected gain of $4.21 Billion • Bottles (Segmentation By Product) → Expected gain of $3.12 Billion • Ampoules (Segmentation By Product) → Expected gain of $1.84 Billion

What Is Covered Under Pharmaceutical Glass Packaging Market?

Pharmaceutical glass packaging refers to a type of glass container which is prepared by a combination of different materials that are designed to ensure the safe transportation of various acidic and medical items. The use of glass in pharmaceutical packaging has many benefits, as glass is incredibly resistant to temperature changes. The main types of pharmaceutical glass packaging are ampoules, bottles, vials, syringes, cartridges, and other products. The ampoules refer to the sealed glass-containing solutions for hypodermic injections. Ampoules are used as packaging for many cosmetic and pharmaceutical products. The various drug types include generics, branded, and biologics that are made of different materials, such as type I, type II, and type III. The several applications include oral, injectable, nasal, and others.

What Is The Pharmaceutical Glass Packaging Market Growth Forecast?

The pharmaceutical glass packaging market size is expected to see rapid growth in the next few years. It will grow to $27.35 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to rising production of biologics, increasing reliance on high integrity packaging, growing regulatory emphasis on medical safety, strengthening need for durable pharmaceutical storage, expanding pharmaceutical distribution networks. Major trends in the forecast period include increasing demand for safe pharmaceutical storage, growing adoption of high quality medical packaging, rising focus on contamination free drug containers, strengthening dependence on temperature stable packaging, increasing use of specialized pharmaceutical glass solutions.

What Is The Driver Of The Pharmaceutical Glass Packaging Market?

The growth of the pharmaceutical industry is expected to propel the growth of the pharmaceutical glass packaging market going forward. The pharmaceutical industry refers to the discovery, development, and manufacture of medications and drugs. Pharmaceutical glass packaging is used to pack and store medicines, strong alkalis, and acids. For instance, in 2023, according to the Zippia, an US-based leading information platform, the U.S. pharmaceutical industry makes up 43.7% of the global pharmaceutical market in 2023. Therefore, the growth of the pharmaceutical industry is driving the growth of the pharmaceutical glass packaging industry.

How Will The Drivers Impact Growth In The Global Pharmaceutical Glass Packaging Market?

• Rising Demand For Injectable Drugs And Biologics (High) – During the forecast period, the rising demand for injectable drugs and biologics is expected to become a key growth driver for the pharmaceutical glass packaging market by 2030. The increasing prevalence of chronic diseases and the shift toward targeted therapies are accelerating the development and commercialization of biologics, vaccines, and specialty injectables. These therapies require high-quality glass containers such as vials, ampoules, and cartridges that ensure sterility and compatibility with complex formulations. Pharmaceutical companies are expanding production capacities for injectable drugs, thereby increasing demand for reliable packaging solutions. • Superior Chemical Resistance And Product Stability (Medium) – During the forecast period, superior chemical resistance and product stability offered by glass packaging is expected to emerge as a major factor driving the expansion of the pharmaceutical glass packaging market by 2030. Glass materials provide excellent barrier properties, preventing interactions between the container and sensitive drug formulations, which is critical for maintaining efficacy and shelf life. Unlike alternative materials, glass does not leach harmful substances or react with active pharmaceutical ingredients, making it a preferred choice for high-value and sensitive medications. Continuous advancements in glass composition and surface treatments are further enhancing performance characteristics. • Stringent Regulatory Standards For Drug Safety (Medium) – During the forecast period, the stringent regulatory standards for drug safety are expected to act as a key growth catalyst for the pharmaceutical glass packaging market by 2030. Regulatory authorities across major markets are enforcing strict guidelines for primary packaging to ensure product integrity, sterility, and patient safety. Compliance requirements related to particulate contamination, extractables and leachables, and packaging validation are driving pharmaceutical companies to adopt high-quality glass solutions. Manufacturers are increasingly investing in quality control systems and certified production processes to meet these standards. As regulatory scrutiny intensifies globally, the demand for compliant and reliable glass packaging solutions is expected to rise.

How Will The Restraints Impact Growth In The Global Pharmaceutical Glass Packaging Market?

• High Production And Energy Costs (High) – During the forecast period, high production and energy costs are significantly restricting the growth of the pharmaceutical glass packaging market. Energy-intensive manufacturing processes, coupled with rising raw material and fuel costs, are increasing overall production expenses and reducing profit margins for packaging producers. • Fragility And Risk Of Breakage During Transportation (Medium) – During the forecast period, fragility and risk of breakage during transportation are restricting the growth of the pharmaceutical glass packaging market. The inherent brittleness of glass leads to higher logistics costs, product losses, and the need for specialized handling and packaging solutions, increasing overall operational challenges. • Competition From Alternative Packaging Materials (Medium) – During the forecast period, competition from alternative packaging materials is restricting the growth of the pharmaceutical glass packaging market. The increasing adoption of plastic, polymer-based, and hybrid packaging solutions is shifting demand away from traditional glass formats, particularly in applications prioritizing lightweight and cost-efficient solutions.

Key Players In The Global Pharmaceutical Glass Packaging Market

Major companies operating in the pharmaceutical glass packaging market report are AGC Inc., Corning Inc., Şişecam, Ardagh Group S.A., O-I Glass Inc., Hoya Corporation, Nipro Corp, Bormioli Pharma SpA, Gerresheimer AG, Wheaton Industries Inc., Shandong Pharmaceutical Glass Co Ltd., Hindusthan National Glass & Industries Limited, Yoshino Glass Co Ltd., Stolzle Glass Group, Schott AG, Beatson Clark, Arab Pharmaceutical Glass Co, Acme Vial & Glass Co, United Glass Company, SGD SA, Yamamura Glass Co Ltd., Toyo Glass Co Ltd., NEG Group Co Ltd.

Global Pharmaceutical Glass Packaging Market Trends and Insights

Major companies operating in the pharmaceutical glass packaging market are focusing on innovating products such as the glass jars, to provide a competitive edge in the market. Glass jars are cylindrical or slightly conical container, made of glass, ceramic, or plastic, with a wide mouth or opening that can be closed with a lid, screw cap, lug cap. For instance, in October 2023, Stoelzle Pharma, an Austria-based pharmaceutical glass packaging company, launched PharmaCos packaging line. PharmaCos packaging line is a new line of glass jars and bottles ranging from 5ml (milliliters) to 500ml (milliliters) in amber color with a screw neck design, as well as flat-shoulder bottles from 20ml (milliliters) to 150ml (milliliters). It is designed to provide a sustainable choice for healthcare products, with high recycled glass contents of 73% recycled content in amber glass and 38% in flint glass.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Glass Packaging Market?

In August 2025, SGD Pharma, a France-based provider of pharmaceutical primary packaging solutions including glass vials, ampoules, and ready-to-use (RTU) products for injectable drugs and biologics, acquired Alphial S.r.l. for an undisclosed amount. With this acquisition, SGD Pharma aims to broaden its tubular glass converting capabilities in Europe, reinforce its regional manufacturing footprint, and enhance its product portfolio to better serve global pharmaceutical customers with expanded capacity and localized supply chain solutions. Alphial S.r.l. is an Italy-based provider of tubular glass products focused on manufacturing ampoules, vials, and RTU glass packaging for the pharmaceutical industry across multiple European sites.

What Defines the Pharmaceutical Glass Packaging Market?

The pharmaceutical glass packaging market consists of sales of borosilicate glass, treated soda-lime glass, regular soda-lime glass, and general purpose soda-lime. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Glass Packaging Market Report 2026?

The pharmaceutical glass packaging market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical glass packaging industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.